Site # 210 — Charlottesville, Virginia

Site # 210 is a clinical research site located in Charlottesville, Virginia, United States 22908.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site # 210 has participated in 1 clinical trials.

Therapeutic areas: Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma.

Sponsors: Pharmacyclics LLC..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Charlottesville

Browse all research sites in Virginia · View every site in Charlottesville

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site # 210?

Site # 210 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site # 210 conducted?

Site # 210 has 1 clinical trials on record. Their work covers Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma.

Is Site # 210 accredited by Crixeo Clinical Trials?

Site # 210 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site # 210?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.